These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6103510)

  • 21. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
    Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
    Foz M
    Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug trials in myocardial infarction. Lessons to be learned from the Anturane Reinfarction Trial.
    Sherry S
    Eur J Clin Pharmacol; 1980 Jun; 17(6):401-7. PubMed ID: 7398732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Adrenergic blocking agents in the post-myocardial infarction patient.
    Goldstein S
    Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blockade after myocardial infarction.
    Drug Ther Bull; 1977 Apr; 15(9):33-4. PubMed ID: 17532
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
    Anturane Reinfarction Trial Research Group
    N Engl J Med; 1980 Jan; 302(5):250-6. PubMed ID: 6985706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfinpyrazone after myocardial infarction.
    N Engl J Med; 1978 Jun; 298(22):1257-9. PubMed ID: 349383
    [No Abstract]   [Full Text] [Related]  

  • 30. More on sulfinpyrazone after myocardial infarction.
    Hood WB
    N Engl J Med; 1982 Apr; 306(16):988-9. PubMed ID: 7038499
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of the patient after myocardial infarction. The last decade and the next.
    Braunwald E
    N Engl J Med; 1980 Jan; 302(5):290-3. PubMed ID: 6101290
    [No Abstract]   [Full Text] [Related]  

  • 32. Anturane reinfarction trial.
    Evans DW
    Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction in the severity of myocardial infarction by sulfinpyrazone.
    Innes IR; Weisman H
    Am Heart J; 1981 Aug; 102(2):153-7. PubMed ID: 7258086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockers: the promise, the problem.
    Rogers FJ
    J Am Osteopath Assoc; 1981 May; 80(9):584-5. PubMed ID: 6114078
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
    Latour JG; Theroux P; Bourassa MG
    Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis of myocardial infarction.
    de Bono DP
    Scott Med J; 1981 Jul; 26(3):194-6. PubMed ID: 6115470
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA says no to anturane.
    Kolata GB
    Science; 1980 Jun; 208(4448):1130-2. PubMed ID: 6990491
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease.
    Friedewald WT; Schoenberger JA
    Control Clin Trials; 1982 Sep; 3(3):259-70. PubMed ID: 6129942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved prognosis during long-term treatment with beta-blockers after myocardial infarction: analysis of randomized trials and pooling of results.
    Bassan MM; Shalev O; Eliakim A
    Heart Lung; 1984 Mar; 13(2):164-8. PubMed ID: 6142030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infarction prophylaxis--prevention of the sudden heart death? An alternative].
    Gross F
    MMW Munch Med Wochenschr; 1982 May; 124(18):435-6. PubMed ID: 6124885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.